Many team members at Unicorn Nest are Ukrainians affected by Russian aggression. We do our best to solve any issues and answer your questions in the shortest possible time frames but some delays are possible.

XtalPi

Founders Jian Ma Lipeng Lai Shuhao Wen

Overview

Investments

Unlock datapoints

Portfolio analytics

Team

News & Media

Add fund to favorites
info
Save this fund for later to form your own custom list of funds
This summary is composed by our algorithm based on the analysis of the deals. If you think that some of this information is not accurate, please let us know about it and provide any supporting evidences if possible. Such cases will be analyzed by our ML-algorithm and implemented in our database, which will improve this summary.

Need help with fundraising?

We offer an assisted fundraising option for startups

Learn more
Total investments 7
Average round size
info
The average size of a deal this fund participated in
$14M
Portfolio companies 7
Rounds per year 0.70
Lead investments 0
Key employees Soon

Areas of investment

  • Biotechnology
  • Pharmaceutical
  • Health Care
  • Medical
  • Artificial Intelligence

Look at other 50 related and similar funds Collapse list
Fund NameLocation
BCE Capital Massachusetts, United States, Waltham
Dorchester Capital Oklahoma, Oklahoma City, United States
Extreme Innovations Canada, Ontario, Toronto
FarSight Capital -
Genome Canada Canada, Ontario, Ottawa
Jinguang Zijin China, Jiangsu, Nanjing
Neste Espoo, Finland, Uusimaa
Persistent Energy Partners New York, New York, United States
The Royal Bank of Scotland City of Edinburgh, Scotland, United Kingdom
TMFOX VENTURE PARTNERS China, Guangdong, Shenzhen

Notable deals

CompanyIndustryRound SizeDateInvestorsLocation

ReviR Therapeutics

Alternative Medicine
Biotechnology
Genetics
$30M26 Jul 2024 San Francisco, California, United States

Leman Biotech

Biotechnology
Health Care
Medical
Pharmaceutical
$7M18 Jun 2024 Lausanne, Vaud, Switzerland

Aoshixin

18 Apr 2024 Chengdu, Sichuan, China

CytoCan Corp.

Biotechnology
Pharmaceutical
$1M07 Feb 2023 Shangcheng, Shaanxi, China

META Pharmaceuticals

Medical
Pharmaceutical
$15M13 Jun 2022 Shenzhen, Guangdong, China

PhoreMost

Biopharma
Biotechnology
Health Care
$45M23 Mar 2021 Cambridge, England, United Kingdom

Artificial Intelligence
23 Mar 2020 Zhejiang

Review

  • No reviews are submitted yet.
Do you want more?
We provide dozens of additional datapoints about this fund.
Sign up and get access to full fund profile and advanced analysis.
Full team
Industries heatmap
Stages heatmap
Georgaphy breakdown
Coinvestors
Portfolio analysis
Performance indexes
Latest highlights
Unlock all data
Do you represent XtalPi?
Get access to manage this page
Get in touch
Found incorrect info? Let us know!
Total investments 7
Average round size 14M
Rounds per year 0.70
Peak activity year 2024
Lead investments 0
Group Appearance index 1.00

Latest deals

CompanyIndustryRound SizeDateInvestorsLocation

ReviR Therapeutics

Alternative Medicine
Biotechnology
Genetics
$30M26 Jul 2024 San Francisco, California, United States

Leman Biotech

Biotechnology
Health Care
Medical
Pharmaceutical
$7M18 Jun 2024 Lausanne, Vaud, Switzerland

Aoshixin

18 Apr 2024 Chengdu, Sichuan, China

CytoCan Corp.

Biotechnology
Pharmaceutical
$1M07 Feb 2023 Shangcheng, Shaanxi, China

META Pharmaceuticals

Medical
Pharmaceutical
$15M13 Jun 2022 Shenzhen, Guangdong, China

PhoreMost

Biopharma
Biotechnology
Health Care
$45M23 Mar 2021 Cambridge, England, United Kingdom

Artificial Intelligence
23 Mar 2020 Zhejiang
Crunchbase icon

Content report

The following text will be sent to our editors: